TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

New indication based on results from a global Phase 3 trial demonstrating significantly improved overall survival benefit for PD-L1 positive patients treated with TEVIMBRA in combination with chemothe ...

On World Rare Disease Day, Apollo Hospital Navi Mumbai highlighted a rare medical success story, treating a four-year-old ...

SCID adalah Severe Combined Immunodeficiency alias kelainan genetik yang sangat langka. Kenali gejala, penyebab, hingga ...

There are several broad categories of blood cells, including red blood cells (RBCs), white blood cells (WBCs), and platelets. Generally, leukemia refers to cancers of the WBCs. In leukemia ...

3. 已证实和可能的IFD风险因素 allo-HSCT患者IFD的独立危险因素包括疾病处于晚期（危险比[HR]=2.55；95%置信区间[CI]：1.58-4.12 P<0.001）、绝对中性粒细胞计数(ANC)移植（≤28天）（HR=0.37；95% CI：0.15-0.92 P=0.032）、血小板(PLT)移植（≤28天）（HR=0.41；95% CI：0.27 -0.62 P<0.001 ...

AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of ...

Later that night, PLT posted, “We at Portsmouth Little Theatre would like to thank the community for the outpouring of concern for our injured actor. Our patrons have been so thoughtful and ...